• Media Centre
  • Investor relations
  • Client area
  • Client area
  • Stewardship policy
  • Annual reports service

Form of Proxy

STOKE THERAPEUTICS, INC.

Notes

No. Proposition For Against Abstain
1

DIRECTOR G. Clare Kahn, Ph.D.

2

DIRECTOR Adrian Krainer, Ph.D.

3

DIRECTOR Julie Anne Smith

4

To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026.

5

To approve, on an advisory basis, the compensation of the Companys named executive officers.